HomeMarkets Markets Crispr Surges After Winning The First CRISPR Gene-Editing Approval By news November 16, 2023 0 338 FacebookTwitterPinterestWhatsApp In a world first, regulators in the U.K. approved Crispr Therapeutics’ (CRSP) gene-editing treatment for two blood diseases on Thursday. CRSP stock …This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected156,245FansLike396,312FollowersFollow2,340SubscribersSubscribe Latest Articles Markets Here’s our forecast for AI this year Markets How the CIA director helps the US navigate a world of spies, threats and geopolitical turbulence Markets Firefighting planes are dumping ocean water on the Los Angeles fires − why using saltwater is typically a last resort Markets LA fires: Why fast wildfires and those started by human activities are more destructive and harder to contain Market News 4 reasons why the US might want to buy Greenland – if it were for sale, which it isn’t Markets PhilStockWorld January Portfolio Review (Members Only) Health Surveillance tech is changing our behaviour – and our brains Biotech Moderna shares plunge as company dramatically lowers sales forecast Biotech Longevity-Obsessed Tech Millionaire Discontinues De-Aging Drug Out of Concerns That It Aged Him Energy A Wider War Has Already Started in Europe (shared) AI The dynamics that polarise us on social media are about to get worse Markets Trump’s Day One tariff options carry huge economic, legal risks Markets Monday Morning Melt-Down – Dollar Over 110 Puts Pressure on Everything Else AI Tech companies are turning to ‘synthetic data’ to train AI models – but there’s a hidden cost Load more